Management of Cardiac Implantable Electronic Devices removal with cardiopulmonary bypass: A single center experience

Year 2023, , 187 - 193, 12.06.2023

Timucin Aksu Cigdem Tel Ustunisik

https://doi.org/10.5798/dicletip.1313291

Abstract

Backround: Currently, permanent pacemakers and internal defibrillators are widely used as a result of technological developments. Infection and dysfunction are the most important reasons for removing these devices from patients. Transvenous removal of these devices is the first recommended method. Failure of transvenous methods, presence of endocarditis, large vegetation or thrombus requires the use of surgical methods to remove these devices.
In this study, our purpose is to present our management in surgical removal of cardiac implantable electronic devices (CIED).
Methods: Between June 2017 and October 2019, 667 CIED were implanted and 10 patients underwent surgical removal of CIED in our hospital. The demographic data of the patients were obtained from the polyclinic files and the hospital registration system.
Results: Eight (80%) patients were male and the mean age was 55.3±16.4 years (22.0-77.0). Complete pacemaker system removal was decided by the heart team in all cases. In 4 patients, permanent pacemaker reimplantation was required intraoperatively.
Conclusion: CIED infection is a serious disease associated with high mortality. For this reason, we believe that it should be beneficial to consider the long-term results in determining permanent pacemaker and internal defibrillator indications.

Keywords

Cardiac implantable electronic device, cardiopulmonary bypass, cardiac pacemaker

References

• 1.Bardy GH, Lee KL, Mark DB, et al. Amiodarone or animplantable cardioverter-defibrillator for congestiveheart failure. N Engl J Med. 2005;352(3):225–37.
• 2.Linde C, Abraham WT, Gold MR, et al. Randomizedtrial of cardiac resynchronization in mildlysymptomatic heart failure patients and inasymptomatic patients with left ventriculardysfunction and previous heart failure symptoms. J Am Coll Cardiol. 2008;52(23):1834–43.
• 3.Moss AJ, Hall WJ, Cannom DS, et al. Cardiacresynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361(14):1329–38.
• 4.Cazeau S, Leclercq C, Lavergne T, et al. Effects ofmultisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344(12):873–80.
• 5.Voigt A, Shalaby A, Saba S. Continued rise in rates ofcardiovascular implantable electronic deviceinfections in the United States: temporal trends andcausative insights. Pacing Clin Electrophysiol.2010;33(4):414–9.
• 6.Margey R, McCann H, Blake G, et al. Contemporarymanagement of and outcomes from cardiac devicerelated infections. Europace 2010;12:64-70.
• 7.Baddour LM, Epstein AE, Erickson CC, et al. Updateon cardiovascular implantable electronic deviceinfections and their management: a scientificstatement from the American Heart Association.Circulation 2010;121:458-77.
• 8.Kantharia BK, Kutalek SP. Extraction of pacemakerand implantable cardioverter defibrillator leads. CurrOpin Cardiol 1999 Jan; 14(1):44-51.
• 9.Colavita PG, Zimmern SH, Gallgher JJ, et al.Intravascular extraction of chronic pacemaker leads:efficacy and follow up: Pacing Clin Electrophysiol 1993 Dec; 16(12):2333-6.
• 10.Farooqi FM, Talsania S, Hamid S, et al. Extraction of cardiac rhythm devices: indications, techniques andoutcomes for the removal of pacemaker anddefibrillator leads. Int J Clin Pract 2010;64:1140-7.
• 11.Brodman R, Frame R, Andrews C, et al. Removal ofinfected transvenous leads requiring cardiopulmonary bypass or inflow occlusion. J Thorac Cardiovasc Surg1992; 103:649-54.
• 12.Frame R, Brodman R, Furman S et al. Surgicalremoval of infected transvenous pacemaker leads.Pace 1993 Dec; 16:2343.
• 13.Li JS, Sexton DJ, Mick N, et al. Proposedmodifications to the Duke criteria for the diagnosis ofinfective endocarditis. Clin Infect Dis 2000;30:633–8.
• 14.Bongiorni MG, Burri H, Deharo JC, et al. 2018 EHRAexpert consensus statement on lead extraction:recommendations on definitions, endpoints, researchtrial design, and data collection requirements forclinical scientific studies and registries: endorsed byAPHRS/HRS/LAHRS. Europace. 2018;20((7)):1217–1217. doi: 10.1093/europace/euy050.
• 15.Uslan DZ, Sohail MR, St Sauver JL, et al. Permanentpacemaker and implantable cardioverter defibrillatorinfection: a population-based study. Arch Intern Med2007;167:669-75.
• 16. Johansen JB, Jorgensen OD, Moller M, et al. Infection after pacemaker implantation: infection rates and riskfactors associated with infection in a population-basedcohort study of 46299 consecutive patients. Eur HeartJ.2011;32(8):991–8.
• 17.Lin YS, Hung SP, Chen PR, et al. Risk factorsinfluencing complications of cardiac implantableelectronic device implantation: infection,pneumothorax and heart perforation: a nationwidepopulation-based cohort study. Medicine (Baltimore).2014;93(27):e213.
• 18.Chua JD, Wilkoff BL, Lee I, et al. Diagnosis andmanagement of infections involving implantableelectrophysiologic cardiac devices. Ann Intern Med2000;133:604-8.
• 19.Baddour LM, Bettmann MA, Bolger AF, et al.Nonvalvular cardiovascular device-related infections.Circulation 2003;108:2015-3.
• 20.Sohail MR, Uslan DZ, Khan AH, et al. Infectiveendocarditis complicating permanent pacemaker andimplantable cardioverter-defibrillator infection. MayoClin Proc 2008;83:46-53.
• 21.Villamil Cajoto I, Rodríguez Framil M, Van denEynde Collado A, et al. Permanent transvenouspacemaker infections: An analysis of 59 cases. Eur JIntern Med 2007;18:484-8.
• 22.Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESCGuidelines for the management of infectiveendocarditis: the task force for the management ofinfective endocarditis of the European Society ofCardiology (ESC). Endorsed by: European Associationfor Cardio-Thoracic Surgery (EACTS), the EuropeanAssociation of Nuclear Medicine (EANM). Eur Heart J2015;36:3075–128.
• 23.Sohail MR, Uslan DZ, Khan AH, et al. Managementand outcome of permanent pacemaker andimplantable cardioverter-defibrillator infections. J AmColl Cardiol 2007;49:1851-9.
• 24.del Río A, Anguera I, Miró JM, et al. Surgicaltreatment of pacemaker and defibrillator leadendocarditis: the impact of electrode lead extractionon outcome. Chest 2003;124:1451-9.
• 25.Fozia Zahir Ahmed, Catherine Fullwood, MahvashZaman et al. PLoS One. 2019; 14(1): e0206611.Published online 2019 Jan 2. doi:10.1371/journal.pone.0206611